JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.21B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
Tesla
TSLA
|
+$1.1B |
| 4 |
NXP Semiconductors
NXPI
|
+$1.04B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$998M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.32B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 4 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.31B |
| 5 |
PayPal
PYPL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.74% |
| 2 | Financials | 10.42% |
| 3 | Healthcare | 9.81% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
TIM SA
TIMB
$8.27B
| $15.1M | ﹤0.01% |
1,299,796
+14,117
| +1% | +$160K |
|
2002
PUT
Biogen
BIIB
$31.1B
| $15.1M | ﹤0.01% |
63,000
+29,400
| +88% | +$7.56M |
|
2003
Ocugen
OCGN
$458M
| $15.1M | ﹤0.01% |
3,321,956
+2,762,832
| +494% | +$20.9M |
|
2004
First Trust Cloud Computing ETF
SKYY
$3.38B
| $15.1M | ﹤0.01% |
144,901
+3,448
| +2% | +$380K |
|
2005
Sabre
SABR
$892M
| $15.1M | ﹤0.01% |
1,755,473
-13,543,562
| -89% | -$130M |
|
2006
A10 Networks
ATEN
$1.96B
| $15.1M | ﹤0.01% |
909,345
+23,524
| +3% | +$357K |
|
|
MAXR
2007
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $15.1M | ﹤0.01% |
509,666
+275,812
| +118% | +$8M |
|
2008
DHT Holdings
DHT
$3.09B
| $15M | ﹤0.01% |
2,899,545
+326,527
| +13% | +$1.95M |
|
2009
EQT Corp
EQT
$33.8B
| $15M | ﹤0.01% |
689,652
-69,841
| -9% | -$1.46M |
|
2010
PUT
FedEx
FDX
$80.3B
| $15M | ﹤0.01% |
58,100
+23,700
| +69% | +$5.69M |
|
2011
Nu Skin
NUS
$236M
| $15M | ﹤0.01% |
295,510
+114,061
| +63% | +$5.07M |
|
2012
Huron Consulting
HURN
$2.47B
| $15M | ﹤0.01% |
300,309
+34,029
| +13% | +$1.7M |
|
2013
Chemours
CC
$2.3B
| $15M | ﹤0.01% |
445,700
-39,004
| -8% | -$1.21M |
|
2014
Murphy Oil
MUR
$4.99B
| $14.9M | ﹤0.01% |
572,116
+177,509
| +45% | +$4.91M |
|
2015
Protagonist Therapeutics
PTGX
$9.8B
| $14.9M | ﹤0.01% |
436,453
+7,758
| +2% | +$245K |
|
2016
Rocket Pharmaceuticals
RCKT
$367M
| $14.9M | ﹤0.01% |
683,176
-138,959
| -17% | -$3.79M |
|
2017
Ironwood Pharmaceuticals
IRWD
$674M
| $14.9M | ﹤0.01% |
1,276,908
-489,386
| -28% | -$6M |
|
2018
Abercrombie & Fitch
ANF
$4.84B
| $14.8M | ﹤0.01% |
426,242
+74,885
| +21% | +$2.93M |
|
2019
PUT
PepsiCo
PEP
$192B
| $14.8M | ﹤0.01% |
85,400
+1,500
| +2% | +$245K |
|
2020
Sonic Automotive
SAH
$2.51B
| $14.8M | ﹤0.01% |
299,947
+56,189
| +23% | +$2.82M |
|
|
IRBT
2021
CALL
DELISTED
iRobot
IRBT
| $14.8M | ﹤0.01% |
225,100
-405,200
| -64% | -$32M |
|
2022
PUT
Applied Materials
AMAT
$424B
| $14.8M | ﹤0.01% |
94,200
-4,000
| -4% | -$579K |
|
2023
Sinclair Inc
SBGI
$1.03B
| $14.8M | ﹤0.01% |
559,557
-65,424
| -10% | -$1.75M |
|
|
GWB
2024
DELISTED
Great Western Bancorp, Inc.
GWB
| $14.7M | ﹤0.01% |
434,288
-153,081
| -26% | -$5.23M |
|
2025
Shutterstock
SSTK
$217M
| $14.7M | ﹤0.01% |
132,950
+57,046
| +75% | +$6.64M |
|
Similar funds
JP Morgan Chase's Q4 2021 Portfolio in Review
As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
- JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
- JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
- JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
- JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
- JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.